Etoposide (100 mM)

Details zu Produkt Nr. ABIN412366, Anbieter: Anmelden zum Anzeigen
Functional Studies (Func), Blocking Reagent (BR), Inhibition Assay (InhA)
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Verwendungszweck A topoisomerase II inhibitor
Produktmerkmale Etoposide is an antitumor agent that complexes with topoisomerase II and DNA to enhance double-strand and single-strand cleavage of DNA and reversibly inhibit religation. Blocks the cell cycle in in S-phase and G2-phase of the cell cycle, induces apoptosis in normal and tumor cell lines, inhibits synthesis of the oncoprotein Mdm2 and induces apoptosis in tumor lines that overexpress Mdm2.
Reinheit > 98 % by HPLC
Chemical Name 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside, VP-16-213
Formel C₂₂H₂₉FO₅
Permeabilität Cell-permeable
Löslichkeit DMSO
Molekulargewicht 588.56 g/mol
CAS-Nummer 33419-42-0
Applikations-hinweise We recommend using 1000X dilutions for inducing apoptosis in Jurkat cells (e.g., Add 1 µL to 1 mL of culture medium).
However the optimal doses may vary for different cells and culture conditions.

A topoisomerase II inhibitor. A derivative of podophyllotoxin that has major activity against a number of tumors, including germ cell neoplasms, small cell lung cancer, and malignant lymphoma. Induces apoptosis in human T cells, mouse thymocytes, and HL-60 human leukemia cells

Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Handhabung Protect from light and moisture
Lagerung -20 °C
Haltbarkeit 6 months
Bilder des Herstellers
 image for Etoposide (100 mM) (ABIN412366) Etoposide (100 mM)
Produkt verwendet in: Chen, Colvin, Maier, Mirmira, Fueger: "Mitogen-inducible gene 6 triggers apoptosis and exacerbates ER stress-induced β-cell death." in: Molecular endocrinology (Baltimore, Md.), Vol. 27, Issue 1, pp. 162-71, 2012 (PubMed).

Itamochi, Oishi, Shimada, Sato, Uegaki, Naniwa, Sato, Nonaka, Terakawa, Kigawa, Harada: "Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 17, Issue 14, pp. 4742-50, 2011 (PubMed).

Xia, Ma, Sun, Yang, Peng: "Retinoic acid metabolizing enzyme CYP26A1 is implicated in rat embryo implantation." in: Human reproduction (Oxford, England), Vol. 25, Issue 12, pp. 2985-98, 2010 (PubMed).

Bhola, Simon: "Determinism and divergence of apoptosis susceptibility in mammalian cells." in: Journal of cell science, Vol. 122, Issue Pt 23, pp. 4296-302, 2009 (PubMed).

Jensen, Andresen, Hansen, Skov: "Cell-surface expression of Hsp70 on hematopoietic cancer cells after inhibition of HDAC activity." in: Journal of leukocyte biology, Vol. 86, Issue 4, pp. 923-32, 2009 (PubMed).

Lin, Chen, Chang, Jan, Hsu, Wu, Fang, Tang, Chang, Lin: "Bcl-2 rescues ceramide- and etoposide-induced mitochondrial apoptosis through blockage of caspase-2 activation." in: The Journal of biological chemistry, Vol. 280, Issue 25, pp. 23758-65, 2005 (PubMed).